IL33 and obesity disorder: Conversely, stimulation of adipose tissue with obese-derived VAT determined a slight reduction in the expression of ST2L while soluble sST2 did not vary, suggesting deregulation in IL-33/ST2L pathway due to obesity (Figure 6b,c).